---
title: Stable Ischemic Disease
author: J. Austin Straley, DO
date: 2024-03-16
categories:
    - Cardiology
---
## Coronary Artery Disease (CAD)
- Management
    - [4S: Statins reduce Death, MI, Revasc in Angina/MI patients](https://pubmed.ncbi.nlm.nih.gov/7968073/){:target="_blank"}
    - [SATURN: Crestor better LDL reduction, no better mortality than Lipitor](https://pubmed.ncbi.nlm.nih.gov/22085316/){:target="_blank"}
        - Atorvastatin (Lipitor)
            - [Muscle toxicity w/concurrent Amiodarone use (0.7%)](https://pubmed.ncbi.nlm.nih.gov/15860984/){:target="_blank"}
        - Rosuvastatin (Crestor)
            - [Crestor FDA (Renal Dosing)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021366s040s041lbl.pdf){:target="_blank"}
            - [Crestor to prevent vascular events in patients with elevated CRP](https://pubmed.ncbi.nlm.nih.gov/18997196/){:target="_blank"}
        - Side Effects
            - [Statin induced diabetes and its clinical implications](https://pubmed.ncbi.nlm.nih.gov/25210397/){:target="_blank"}
            - [Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis](https://pubmed.ncbi.nlm.nih.gov/21693744/){:target="_blank"}
            - [Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials](https://pubmed.ncbi.nlm.nih.gov/20167359/){:target="_blank"}
            - [Statin-Associated Myopathy](https://pubmed.ncbi.nlm.nih.gov/12672737/){:target="_blank"}
                - [Adverse events with concomitant amiodarone and statin therapy](https://pubmed.ncbi.nlm.nih.gov/15860984/){:target="_blank"}
            - [Asymptomatic hypothyroidism and statin-induced myopathy](https://pubmed.ncbi.nlm.nih.gov/17872677/){:target="_blank"}
    - [COURAGE: PCI w/BMS in Stable CAD non-superior to medical therapy](https://pubmed.ncbi.nlm.nih.gov/17387127/){:target="_blank"}
    - [In life expectancy <1, discontinuation of statin did not increase 60-day mortality](https://pubmed.ncbi.nlm.nih.gov/20818875/){:target="_blank"}